Sly Saint
Senior Member (Voting Rights)
Abstract
Study objectives:
To evaluate the psychometric properties and clinical significance of a new scale for measuring daytime fatigue associated with insomnia: The Flinders Fatigue Scale (FFS).
Methods:
The 7-item FFS was used in two separate studies. Study 1 was an on-line validation study involving 1093 volunteers (mean [SD] age = 38.6 [14.7] y, 626 poor sleepers, 467 good sleepers) in a cross-sectional design; Study 2 investigated the clinical sensitivity of the FFS on 113 insomnia patients (mean [SD] age = 48.3 [15.0] y) in response to a 5-week cognitive-behavior therapy for insomnia (CBT-I) program.
Results:
The FFS had an internal consistency of 0.91; it comprised a single factor, accounting for 67% of the total variance. Poor sleepers in Study 1 scored significantly higher than good sleepers on the FFS (p < 0.0001). In Study 2, significant reductions in FFS scores were found in response to CBT-I (p < 0.0001). These reductions in fatigue correlated with improvements on subjective sleep parameters (all p < 0.0001). The FFS showed good discriminant validity with the Epworth Sleepiness Scale.
Conclusions:
The Flinders Fatigue Scale is a brief, clinically sensitive measure with strong psychometric properties.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2556916/
Study objectives:
To evaluate the psychometric properties and clinical significance of a new scale for measuring daytime fatigue associated with insomnia: The Flinders Fatigue Scale (FFS).
Methods:
The 7-item FFS was used in two separate studies. Study 1 was an on-line validation study involving 1093 volunteers (mean [SD] age = 38.6 [14.7] y, 626 poor sleepers, 467 good sleepers) in a cross-sectional design; Study 2 investigated the clinical sensitivity of the FFS on 113 insomnia patients (mean [SD] age = 48.3 [15.0] y) in response to a 5-week cognitive-behavior therapy for insomnia (CBT-I) program.
Results:
The FFS had an internal consistency of 0.91; it comprised a single factor, accounting for 67% of the total variance. Poor sleepers in Study 1 scored significantly higher than good sleepers on the FFS (p < 0.0001). In Study 2, significant reductions in FFS scores were found in response to CBT-I (p < 0.0001). These reductions in fatigue correlated with improvements on subjective sleep parameters (all p < 0.0001). The FFS showed good discriminant validity with the Epworth Sleepiness Scale.
Conclusions:
The Flinders Fatigue Scale is a brief, clinically sensitive measure with strong psychometric properties.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2556916/
Both the DSM-IV and the ICSD-2 indicate a number of typical daytime consequences of insomnia. These include fatigue, malaise, poor attention and concentration, memory impairment, social or vocational dysfunction, irritability, mood disturbance, daytime sleepiness, lack of motivation or energy, prone to accidents, physical symptoms (e.g., headaches, gastrointestinal complaints), and concerns or worries about sleep; which can lead to a reduced quality of life.15 Of all these daytime symptoms, fatigue appears to be the most prevalent daytime complaint, as evidenced by both its emphasis in the scientific literature,4 and in clinical settings.11 Indeed, self-reported fatigue is higher in people experiencing insomnia compared to other sleep disorders (e.g., obstructive sleep apnea), yet comparable to that of cancer and chronic fatigue syndrome.16,17 Fatigue associated with insomnia can be considered as subjective feelings of tiredness, weariness and exhaustion,18 as opposed to the likelihood to doze or fall asleep, which is often associated with daytime sleepiness.19 To date, the most popular measures of fatigue used in insomnia research are the Fatigue Severity Scale (FSS)20 and the Multidimensional Fatigue Inventory (MFI).21
The FSS is a self-report questionnaire, designed to measure the level of a person's fatigue in a variety of situations (e.g., “I am easily fatigued,” “Exercise brings on my fatigue”).20 It is a relatively brief measure, containing only 9 items that provide a global measure of fatigue, and was originally developed on clinical samples (e.g., multiple sclerosis, lupus). In contrast, the MFI contains 20 items divided into 5 subscales: general fatigue (e.g., “I feel tired”), physical fatigue (e.g., “Physically I feel only able to do a little”), reduction in activities (e.g., “I feel very active”), reduction in motivation (e.g., “I dread having to do things”), and mental fatigue (e.g., “My thoughts easily wander”),21 though no global fatigue score is provided. The MFI was primarily developed to measure fatigue in cancer patients. Both measures possess good internal consistency (e.g., FSS α = 0.80; MFI α = 0.84), characteristics essential for a valid daytime impairment measure in treatment outcome studies.11 One criticism of the FSS, however, is the scale's questionable validity (i.e., it includes “fatigue” in each item without providing an initial description of the term).4
Not only do self-reported measures require strong psychometric properties, but they also need to be sensitive to treatment.11 Unfortunately, recent treatment outcome studies using these scales have not delivered promising results.